Axon Enterprise (AXON) Valuation Check After Radar Partnership And New Public Safety Software Launches

Axovant Sciences Ltd

Axovant Sciences Ltd

AXON

0.00

Axon Enterprise (AXON) is back in focus after Echodyne agreed to integrate its MESA radar into Axon’s public safety drone ecosystem, alongside the April launches of Axon Vision, Axon Assistant, and Axon 911.

The recent drone and radar push comes as Axon’s share price has climbed 23.0% over the past week and 22.3% over the past month, yet remains down 14.6% year to date. This has resulted in a much weaker 1 year total shareholder return compared with very strong 3 and 5 year total shareholder returns. This suggests that long term momentum has cooled while shorter term interest is picking up around these product launches and governance updates.

If Axon’s drone and AI tools have caught your attention, it can also be worth scanning the wider opportunity set in AI infrastructure and hardware through the 48 AI infrastructure stocks

With Axon’s stock up sharply in the past month but still down over the past year, and analysts’ published price targets sitting well above the recent US$481.48 close, should you see value here or assume the market is already pricing in future growth?

Most Popular Narrative: 20.7% Undervalued

According to the most followed narrative on Axon Enterprise, a fair value of $606.83 sits well above the recent $481.48 close, framing the stock as priced below that narrative view.

One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.

Want to see what sits behind that higher fair value, according to AryaWinningSon? The narrative leans heavily on faster revenue growth, expanding margins, and a richer future profit multiple for Axon’s software powered platform.

Result: Fair Value of $606.83 (UNDERVALUED)

However, this hinges on Axon sustaining software adoption and margins while managing execution risks in public safety, including procurement cycles, regulation and pressure on policing budgets.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another View: Price Signals A Premium

That 20.7% “undervalued” narrative sits alongside a much richer current P/S ratio of 13x. This is far above the US Aerospace & Defense industry at 5.3x and peers at 7.8x, although still below the fair ratio estimate of 15.7x. This points to real valuation risk if expectations slip.

NasdaqGS:AXON P/S Ratio as at Jun 2026
NasdaqGS:AXON P/S Ratio as at Jun 2026

Next Steps

Mixed signals so far, right, with upside potential and real concerns sitting side by side. Take a closer look at both before you decide, starting with the 1 key reward and 3 important warning signs.

Looking for more investment ideas?

If Axon has sharpened your interest, do not stop here. Widen your search and let a few focused stock lists spark your next round of research.

  • Target strong cash generators with healthy balance sheets by scanning the solid balance sheet and fundamentals stocks screener (47 results) for companies that aim to keep risk in check while supporting future decisions.
  • Hunt for pricing gaps by reviewing the 47 high quality undervalued stocks and see which stocks currently trade below their assessed fair value range.
  • Prioritise quality plus potential by checking the screener containing 22 high quality undiscovered gems and spot companies that have not yet attracted broad attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.